Pharmaceutical
Health
Therapy

Corcept Therapeutics

$10.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-1.62%) Today
+$0.15 (1.45%) After Hours

Why Robinhood?

You can buy or sell CORT and other stocks, options, ETFs, and crypto commission-free!

About

Corcept Therapeutics Incorporated Common Stock, also called Corcept Therapeutics, is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Read More Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Employees
166
Headquarters
Menlo Park, California
Founded
1998
Market Cap
1.18B
Price-Earnings Ratio
16.98
Dividend Yield
0.00
Average Volume
1.31M
High Today
$10.61
Low Today
$10.30
Open Price
$10.57
Volume
252.82K
52 Week High
$20.00
52 Week Low
$9.14

Collections

Pharmaceutical
Health
Therapy
Technology

News

Yahoo FinanceMay 19

Edited Transcript of CORT earnings conference call or presentation 9-May-19 9:00pm GMT

Q1 2019 Corcept Therapeutics Inc Earnings Call MENLO PARK May 20, 2019 (Thomson StreetEvents) -- Edited Transcript of Corcept Therapeutics Inc earnings conference call or presentation Thursday, May 9, 2019 at 9:00:00pm GMT TEXT version of Transcript Scroll to continue with content Ad ================================================================================ Corporate Participants ================================================================================ * Andreas Grauer Corcept Therapeut...

15
Yahoo FinanceMay 9

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm

31
Yahoo FinanceMay 9

Corcept Therapeutics Q1 Earnings Top Estimates

Endo (ENDP) delivered earnings and revenue surprises of 26.19% and 4.07%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

34

Earnings

$0.13
$0.17
$0.20
$0.24
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.